LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

Home・Elenco Azioni・Pulse Biosciences Inc

Pulse Biosciences Inc

Chiusa

SettoreSettore sanitario

24.95 -2.39

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

24.84

Massimo

26.86

Metriche Chiave
By Trading Economics
Entrata	-1.1M -19M
Vendite	137K 401K
EPS	-0.241
Margine di Profitto	-4,633.666
Dipendenti	116
EBITDA	-1.4M -19M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+17.14% upside

Dividendi
By Dow Jones
Utili prossimi	11 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	277M 1.8B
Apertura precedente	27.34
Chiusura precedente	24.95

Notizie sul Sentiment di mercato

By Acuity

50%

174 / 345 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

16.59 / 17.17 Supporto e resistenza

Pulse Biosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

19 mag 2026, 20:36 UTC

Acquisizioni, Fusioni, Takeovers

Analog Devices to Buy Empower Semiconductor for $1.5 Billion

19 mag 2026, 23:47 UTC

Discorsi di Mercato

Nikkei May Decline as Concerns About Energy, Material Costs Persists -- Market Talk

19 mag 2026, 23:34 UTC

Discorsi di Mercato

Gold Edges Higher on Possible Technical Recovery -- Market Talk

19 mag 2026, 23:28 UTC

Discorsi di Mercato

Utili

Global Forex and Fixed Income Roundup: Market Talk

19 mag 2026, 23:28 UTC

Discorsi di Mercato

Utili

F&P Healthcare's Outlook Key for Investors -- Market Talk

19 mag 2026, 23:10 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

19 mag 2026, 23:10 UTC

Discorsi di Mercato

Kiwi Property's Dividend Growth Reliant on Several Factors -- Market Talk

19 mag 2026, 22:02 UTC

Utili

ZTO Express (Cayman): Di Xu to Resign From Board

19 mag 2026, 22:01 UTC

Utili

ZTO Express (Cayman) 1Q Adj EPS 43c >ZTO

19 mag 2026, 22:01 UTC

Utili

ZTO Express (Cayman) 1Q EPS 39c >ZTO

19 mag 2026, 22:00 UTC

Utili

ZTO Express (Cayman) 1Q Rev $1.93B >ZTO

19 mag 2026, 21:37 UTC

Utili

Cracks Are Starting to Appear in the Chip Stock Rally -- Barrons.com

19 mag 2026, 21:31 UTC

Acquisizioni, Fusioni, Takeovers

How NextEra Can Fix Dominion's Strange AI Problem -- Barrons.com

19 mag 2026, 21:01 UTC

Utili

Home Depot Beats Earnings Estimates as Shoppers Defy Inflation Fears. The Stock Advances. -- Barrons.com

19 mag 2026, 20:58 UTC

Utili

These Stocks Are Today's Movers: CoreWeave, Nvidia, Home Depot, Akamai, Agilysys, Micron, and More -- Barrons.com

19 mag 2026, 20:46 UTC

Azioni calde

Stocks to Watch Recap: ServiceNow, Home Depot, CoreWeave -- WSJ

19 mag 2026, 20:43 UTC

Discorsi di Mercato

Canada 30-Year Yield Hits Highest Level Since 2010 -- Market Talk

19 mag 2026, 20:34 UTC

Utili

James Hardie Industries Sees FY27 Sales $5.25B-$5.41B >JHX

19 mag 2026, 20:32 UTC

Utili

James Hardie Industries: Targeting Pro Forma Adjusted EBITDA Growth of 4% to 8% in FY27 >JHX

19 mag 2026, 20:32 UTC

Utili

James Hardie Industries 4Q EPS 5c >JHX

19 mag 2026, 20:32 UTC

Utili

James Hardie Industries 4Q Sales $1.4B >JHX

19 mag 2026, 20:21 UTC

Acquisizioni, Fusioni, Takeovers

Analog Devices to Buy Empower Semiconductor for $1.5B

19 mag 2026, 20:18 UTC

Discorsi di Mercato

Canada CPI Data Has Accounting Quirk Related to Travel Tours -- Market Talk

19 mag 2026, 20:13 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

19 mag 2026, 20:13 UTC

Discorsi di Mercato

'Hard to Square' Canada Rate Hikes Expectations Given Mild Core -- Market Talk

19 mag 2026, 20:03 UTC

Acquisizioni, Fusioni, Takeovers

Analog Devices: Deal Further Advances Position as Strategic, System-Level Grid-To-Core Power Partner for Hyperscalers, AI Silicon Developers >ADI

19 mag 2026, 20:03 UTC

Acquisizioni, Fusioni, Takeovers

Analog Devices: Phillips Will Continue Leading IVR Technology Efforts as Part of ADI >ADI

19 mag 2026, 20:02 UTC

Acquisizioni, Fusioni, Takeovers

Analog Devices Will Acquire Empower in All-Cash Transaction for $1.5 B >ADI

19 mag 2026, 20:02 UTC

Acquisizioni, Fusioni, Takeovers

Analog Devices to Acquire Empower Semiconductor, Expanding Its Next-Generation High-Density Power Portfolio for the AI Era

19 mag 2026, 19:23 UTC

Discorsi di Mercato

Oil Futures Slip With Market Back on U.S.-Iran Deal Watch -- Market Talk

Confronto tra pari

Modifica del prezzo

Pulse Biosciences Inc Previsione

Obiettivo di Prezzo

By TipRanks

17.14% in crescita

Previsioni per 12 mesi

Media 30 USD 17.14%

Alto 30 USD

Basso 30 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Pulse Biosciences Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

2 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 2 che hanno fornito valutazioni azionarie a Pulse Biosciences Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

16.59 / 17.17Supporto e resistenza

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

174 / 345 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.